If the Drug Enforcement Administration’s (DEA) Schedule I classification of the most lethal substances looked like a TV crime show lineup of killer suspects, we’d see a slow pan of scary mugs, as follows:
According to the DEA, Schedule I substances have:
Marijuana was dubbed a Schedule I drug in 1970; not ironically, this was the same time the Nixon Administration reportedly framed the hippie demographic in an effort to silence the opposition to the president’s agenda.
Now, the American Medical Association and the American Academy of Pediatrics have asked the DEA to downgrade marijuana, stating that it has therapeutic use for epilepsy and many chronic pain ailments.
The DEA sent a lengthy correspondence to lawmakers in April responding to requests and data supporting declassifying marijuana. The letter was signed and sealed by the heads of the DEA, the Office of National Drug Control Policy and the Department of Health and Human Services, HHS. In it, they state that the DEA has received scientific and medical evaluations plus a scheduling recommendation from HHS.
Currently, marijuana is coded as more dangerous than methamphetamines and cocaine, which are Schedule II drugs.
The DEA affirmed it aims to release a decision by the end of June.
The Sovereign Health Group is a nationwide leader in mental health rehabilitation, offering holistic treatment for manifestations thereof: eating disorders, substance abuse and dual diagnosis of mental disorder and addiction. We keep readers abreast on the latest in clinical breakthroughs, health-related politics and emerging modalities for recovery or wellness.
About the author
Sovereign Health Group staff writer Kristin Currin-Sheehan is a mindful spirit swimming in metaphysical pools with faith as her compass. Her cover: a 30s-something Cinderella breadwinner of an all-sport blended family. Her repertoire includes writing poetry, lifestyle articles and TV news; editing, radio production and on-camera reporting. For more information and other inquiries about this media, contact the author at firstname.lastname@example.org.